Deciphering the interplay between peripheral and central cytokine- and kynurenine pathways : importance for the pathophysiology of schizophrenia

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  2018-03-26

• Fields of study

  Biology, Medicine, Psychology

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: Relationship with SP transcription factors.

  2017cited by this paper
• Dysregulation of cytokine mediated chemotherapy induced cognitive impairment

  2017cited by this paper
• Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.

  2017cited by this paper
• IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance.

  2016cited by this paper
• Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis

  2016influential reference
• Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia.

  2016cited by this paper
• Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.

  2015cited by this paper
• Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors

  2015cited by this paper
• How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis.

  2015cited by this paper
• Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.

  2015influential reference
• A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder

  2015influential reference
• The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond.

  2015cited by this paper
• Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine

  2015cited by this paper
• Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia.

  2014cited by this paper
• IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.

  2014cited by this paper
• Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort.

  2014cited by this paper
• Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer

  2014cited by this paper
• Imbalanced Kynurenine Pathway in Schizophrenia

  2014cited by this paper
• Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.

  2014cited by this paper
• IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis

  2014cited by this paper
• Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.

  2014cited by this paper
• Targeting of NMDA receptors in new treatments for schizophrenia

  2014cited by this paper
• Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.

  2013cited by this paper
• Does Systemic Inflammation Play a Role in Pediatric Psychosis?

  2013influential reference
• Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo

  2013cited by this paper
• Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.

  2013cited by this paper
• Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

  2013cited by this paper
• Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

  2012influential reference
• Pre‐ and postnatal exposure to kynurenine causes cognitive deficits in adulthood

  2012cited by this paper
• Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder

  2012cited by this paper
• Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine.

  2012cited by this paper
• Kynurenines in the mammalian brain: when physiology meets pathology

  2012cited by this paper
• Toxoplasma gondii and other risk factors for schizophrenia: an update.

  2012cited by this paper
• Monocytes in health and disease - Minireview.

  2012cited by this paper
• Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice

  2012cited by this paper
• Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism

  2012cited by this paper
• Impaired monocyte activation in schizophrenia.

  2012cited by this paper
• Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia.

  2012cited by this paper
• Network-Assisted Investigation of Combined Causal Signals from Genome-Wide Association Studies in Schizophrenia

  2012cited by this paper
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

  2011cited by this paper
• Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder.

  2011cited by this paper
• Neuropsychological performance in older patients with schizophrenia: a meta-analysis of cross-sectional and longitudinal studies.

  2011cited by this paper
• Administration of kynurenine during adolescence, but not during adulthood, impairs social behavior in rats.

  2011cited by this paper
• Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia.

  2011cited by this paper
• Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory

  2011cited by this paper
• Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.

  2011influential reference
• Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.

  2011cited by this paper
• An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces.

  2011influential reference
• Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils

  2011cited by this paper
• Human kynurenine aminotransferase II – reactivity with substrates and inhibitors

  2011cited by this paper
• Monocyte recruitment during infection and inflammation

  2011cited by this paper
• Toward an Anti-Inflammatory Strategy for Depression

  2011cited by this paper
• Possible association between Interleukin-1beta gene and schizophrenia in a Japanese population

  2011cited by this paper
• An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

  2011cited by this paper
• Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.

  2011cited by this paper
• The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

  2010cited by this paper
• Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.

  2010cited by this paper
• Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.

  2010cited by this paper
• Reduction of Endogenous Kynurenic Acid Formation Enhances Extracellular Glutamate, Hippocampal Plasticity, and Cognitive Behavior

  2010cited by this paper
• Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.

  2010cited by this paper
• Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases

  2010cited by this paper
• Prenatal infection and schizophrenia: a review of epidemiologic and translational studies.

  2010cited by this paper
• Expression of functional GPR35 in human iNKT cells.

  2010cited by this paper
• Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.

  2009cited by this paper
• Activation of brain interleukin-1β in schizophrenia

  2009cited by this paper
• Blood monocytes: development, heterogeneity, and relationship with dendritic cells.

  2009cited by this paper
• Mammalian nicotinic acetylcholine receptors: from structure to function.

  2009cited by this paper
• Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release

  2009cited by this paper
• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009influential reference
• Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring.

  2009cited by this paper
• The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex

  2009cited by this paper
• Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia.

  2009cited by this paper
• IDO: a double-edged sword for T(H)1/T(H)2 regulation.

  2008cited by this paper
• Comprehensive analysis of polymorphisms throughout GAD1 gene: a family-based association study in schizophrenia

  2008influential reference
• The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

  2008cited by this paper
• Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring.

  2008cited by this paper
• Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis.

  2008cited by this paper
• Molecular basis for detection of invading pathogens in the brain

  2008cited by this paper
• Xanthurenic acid distribution, transport, accumulation and release in the rat brain

  2008cited by this paper
• Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?

  2008cited by this paper
• Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment*

  2008cited by this paper
• Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II.

  2008cited by this paper
• From inflammation to sickness and depression: when the immune system subjugates the brain

  2008influential reference
• Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach.

  2008cited by this paper
• Induction of the kynurenine pathway by neurotropic influenza a virus infection

  2008influential reference
• Characterization of the Kynurenine Pathway in Human Neurons

  2007cited by this paper
• Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis.

  2007cited by this paper
• Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.

  2007cited by this paper
• Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression

  2007influential reference
• Molecules in focus: indoleamine 2,3-dioxygenase.

  2007influential reference
• The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

  2007cited by this paper
• Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?

  2007cited by this paper
• Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.

  2007cited by this paper
• Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth.

  2007cited by this paper
• Structural biology of the LPS recognition.

  2007cited by this paper
• Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.

  2007cited by this paper
• Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines.

  2007cited by this paper
• Polyinosinic Acid Is a Ligand for Toll-like Receptor 3*

  2007influential reference
• Structure and function of Toll receptors and their ligands.

  2007cited by this paper
• Astrocytes are active players in cerebral innate immunity.

  2007cited by this paper

• The Epigenetics of Psychosis: A Structured Review with Representative Loci

  2022cites this paper